Records containing: Recurrent Cervical Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-06An Open-label, Randomized, Controlled, Multicenter, Phase III Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer
-
CLINICAL_TRIALS study record update · 2026-03-16To Validate, Develop and Implement The Scope of Medical Care for Metastatic, Persistent and Recurrent Cervical Cancer Using The Method of Chemoimmunotargeted Therapy
-
CLINICAL_TRIALS study record update · 2026-03-10A Open-label, Single-arm, Multicentre, Phase Ⅱ Study of Evaluate Efficacy and Safety of Anti-PD-1 Combined With Albumin-Bound Paclitaxel in Patients With Recurrent Cervical Cancer
-
CLINICAL_TRIALS study record update · 2025-11-06Phase II Clinical Trial of Eribulin in Advanced or Recurrent Cervical Cancer
-
CLINICAL_TRIALS study record update · 2025-09-22A Prospective, Open-Label, Single-Arm Study of Iparomlimab and Toripalimab Plus Nab-Paclitaxel With or Without Bevacizumab in Recurrent/Metastatic Cervical Cancer Progressed on Anti-PD-(L)1 Therapy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-09-15Clinical Study on the Efficacy and Safety of Disitamab Vedotin Combined With Iparomlimab and Tuvonralimab in the Second-Line Treatment of HER2-Expressing Recurrent Cervical Cancer
-
CLINICAL_TRIALS study record update · 2025-07-20RETRACE Study - Retrospective Observational Study Evaluating Disease Characteristics and Treatment Landscape of High-risk Locally Advanced (LA) or Recurrent / Metastatic (R/M) Cervical Cancer in Italy
-
CLINICAL_TRIALS study record update · 2025-02-28A Phase 2, Multicenter, Single Arm, Open Label Study to Evaluate the Efficacy and Safety of AK104 in Subjects With Recurrent or Metastatic Cervical Cancer
-
CLINICAL_TRIALS study record update · 2022-06-07A Phase II Study of Cabozantinib (XL184) Plus Pembrolizumab for Recurrent, Persistent and/or Metastatic Cervical Cancer
-
CLINICAL_TRIALS study record update · 2021-10-01An Open-label, Phase 2 Randomized Trial of Camrelizumab (SHR1210) Plus Apatinib Versus Paclitaxel and Cisplatin/Carboplatin Plus Bevacizumab as a First-line Therapy in Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
-
CLINICAL_TRIALS study record update · 2020-01-23A Randomized Trial of a Family Caregiver Palliative Care Intervention
-
CLINICAL_TRIALS study record update · 2019-12-20Overall Perspective on the Characteristics of Genetic Mutation in Recurrent Cervical Cancer
-
CLINICAL_TRIALS study record update · 2019-09-12ClinicalTrials.gov study NCT02849340
-
CLINICAL_TRIALS study record update · 2016-06-13Phase I Clinical Trial of Temsirolimus and Vinorelbine in Advanced Solid Tumors.
-
CLINICAL_TRIALS study record update · 2015-10-09A Biobehavioral Intervention for Patients With Gynecologic or Breast Cancer Recurrence
-
CLINICAL_TRIALS study record update · 2015-08-04A Phase 1 Study of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Body Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer
-
CLINICAL_TRIALS study record update · 2015-06-29A Phase II Trial of Bevacizumab (rhuMAB VEGF) (NSC #704865) in the Treatment of Persistent and Recurrent Squamous Cell Carcinoma of the Cervix (Group A)
-
CLINICAL_TRIALS study record update · 2015-02-16A Phase II Study of Sunitinib (SU11248; NSC 736511) an Oral Multi-Targeted Tyrosine Kinase Inhibitor, in Patients With Unresectable, Locally Advanced or Metastatic Cervical Carcinoma
-
CLINICAL_TRIALS study record update · 2013-11-28A Prospective Evaluation of a Palliative Radio-Surgical Approach for the Treatment of Gynecologic Malignancies
-
CLINICAL_TRIALS study record update · 2013-09-30A Phase I Study of UCN-01 in Combination With Irinotecan in Resistant Solid Tumor Malignancies (Part I) and in Triple Negative (ER-Negative, PgR-Negative, HER-2 Not-Amplified) Recurrent Breast Cancers (Part II)
-
CLINICAL_TRIALS study record update · 2013-05-13A Phase 2 Study of Triapine® (NSC #663249) and Cisplatin in Combination With Pelvic Radiation for Treatment of Stage IB2-IVa Cervical Cancer or Stage II-IV Vaginal Cancer
-
CLINICAL_TRIALS study record update · 2013-02-28A Phase I Trial of Herceptin and Interleukin-12
-
CLINICAL_TRIALS study record update · 2013-01-17A Phase II Evaluation Of OSI-774 (NSC #718781) In The Treatment Of Persistent or Recurrent Squamous Cell Carcinoma Of The Cervix
-
CLINICAL_TRIALS study record update · 2013-01-16Phase I Study of OSI-774 (NSC 718781) for Solid Tumors in Patients With Hepatic or Renal Dysfunction
-
CLINICAL_TRIALS study record update · 2013-01-11Phase I Study of Intravenous Triapine® (IND #68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies.